Skip to main content
. 2017 Feb 18;9(5):252–262. doi: 10.4254/wjh.v9.i5.252

Figure 2.

Figure 2

Rates of sustained virological response to telaprevir and simeprevir by prior treatment responses. Percentages indicate the proportion of patients with undetectable serum hepatitis C virus (HCV) RNA levels at 24 wk after the end of treatment. Patient numbers are shown in parenthesis. aP = 0.033 (compared to relapsers in the older patients). NR: Non-responders; TVR: Telaprevir; SMV: Simeprevir; SVR24: Sustained virological response defined as undetectable serum HCV RNA at 24 wk after the end of treatment.